Biomarkers

The LYNX panel analyzes both standard and novel molecular markers in the most common lymphoid neoplasms

Neurodegeneration can be identified using a combination of biomarkers in cerebrospinal fluid of living patients

New protein markers may indicate which patients have stable forms of CLL and which have more aggressive types

Combining urinary biomarkers improves clinical utility and provides a more robust evaluation

More clinically accurate biomarkers could help prevent unnecessary prostate biopsies

With rapid advancements in isolation and purification techniques, the potential role of exosomes as biomarkers in disease pathogenesis is becoming clearer

A longitudinal study of diabetics has linked three proteins with a slower progression of diabetic kidney disease

Other proteins—not just blood—found elevated in colorectal cancer, inflammatory bowel disease

Researchers have identified a protein that could be used to aid in the diagnosis of pancreatic cancer

Sugar and metabolic signatures may help predict duration and probability of HIV remission after antiretroviral therapy